↓ Skip to main content

SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia—a phase II randomised control trial study protocol

Overview of attention for article published in Trials, July 2021
Altmetric Badge

Mentioned by

twitter
13 X users

Citations

dimensions_citation
6 Dimensions

Readers on

mendeley
54 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia—a phase II randomised control trial study protocol
Published in
Trials, July 2021
DOI 10.1186/s13063-021-05373-8
Pubmed ID
Authors

Caroline McCarthy, Joseph Sacco, Stefano Fedele, Michael Ho, Stephen Porter, Triantafillos Liloglou, Bill Greenhalf, Max Robinson, Bridget Young, Silvia Cicconi, Seema Chauhan, Binyam Tesfaye, Richard Jackson, Frances Sherratt, Richard Shaw

X Demographics

X Demographics

The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 54 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 54 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 6 11%
Student > Bachelor 6 11%
Student > Master 4 7%
Student > Doctoral Student 3 6%
Other 3 6%
Other 9 17%
Unknown 23 43%
Readers by discipline Count As %
Medicine and Dentistry 15 28%
Biochemistry, Genetics and Molecular Biology 2 4%
Neuroscience 2 4%
Psychology 2 4%
Immunology and Microbiology 1 2%
Other 6 11%
Unknown 26 48%